Recent news
![[International Guest Researchers] “In conversation” on Evidence Synthesis](https://u-paris.fr/wp-content/uploads/2022/06/Chaimani_Nikolakopoulou-1-1080x675.jpg)
[International Guest Researchers] “In conversation” on Evidence Synthesis
Differences in placebo effects across studies can bias the results of relative effectiveness between interventions. Evidence synthesis and network meta-analysis offer a unique opportunity to study this phenomenon.
![[International Guest Researchers Programme], In Conversation with Jean-François Cottier and Eric MacPhail](https://u-paris.fr/wp-content/uploads/2022/05/Macphail_Cottier_1920px-002-1-1080x675.jpg)
[International Guest Researchers Programme], In Conversation with Jean-François Cottier and Eric MacPhail
Jean-François Cottier, Professor at Université Paris Cité is hosting Professor Eric Macphail from Indiana University based in Bloomington, United States.
Raising Awareness through Training on Green Transition Challenges
By providing a course on Environmental Transition and Societal Issues, Université Paris Cité aims to raise awareness among the student community of the Anthropocene and planetary limitations, equip them with ideas on growth and degrowth, and...
ECOS, An Innovative, International Training Practice for Medical Students
nitiated to put skills and the doctor-patient relationship at the center of student training and evaluation, “ECOS” or “Examen Clinique Objectif et Structuré” is a situational exercise that assesses the skills and knowledge of medical students.
Become a French, Anglophone or Bilingual Volunteer at Nightline
Nightline, a listening service run by and dedicated to students, is recruiting English-speaking or bilingual volunteers, as well as French-speaking volunteers in Paris.
![[CLOVES syndrome] : The U.S. FDA approves Alpelisib based on a French study](https://u-paris.fr/wp-content/uploads/2022/04/julia-koblitz-4AsRcVTJYTw-unsplash-1080x675.jpg)
[CLOVES syndrome] : The U.S. FDA approves Alpelisib based on a French study
AP-HP, Inserm and Université Paris Cité extend their congratulations to Professor Guillaume Canaud’s teams at Necker-Enfants Malades Hospital (AP-HP), Necker-Enfants Malades Institute (INEM), Inserm, Institut Imagine and Université Paris Cité for their work on alpelisib (BYL719), approved by the US Food and Drug Administration (FDA).
Université Paris Cité awarded the “Science with and for Society” Label
On April 13th, the French Ministry of Higher Education, Research and Innovation announced the 12 new winners of the "Science with and for Society" label. (Science avec et pour la société). Université Paris Cité has joined 17 other institutions who have been granted...
![[SARS-CoV-2] Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies](https://u-paris.fr/wp-content/uploads/2022/04/cellules-infectées-par-omicron-1080x675.jpg)
[SARS-CoV-2] Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies
The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of...
Crowd4SDG featured at the Geneva Trialogue 2022
In the context of the Geneva Trialogue, the European research project Crowd4SDG held a hybrid workshop on March 17th called "Closing the gap between institutions and citizen science generated data and solutions". © Geneva Trialogue During the Geneva Trialogue...
International Guest Researchers Programme: An Interview with Olivier Taboureau and Juan Fernandez-Recio
Over the last month, Olivier Taboureau, professor of bioinformatics and biostatistics at Université Paris Cité has been hosting internationally recognized tenured scientist and expert in structural bioinformatics, Juan Fernandez-Recio of the Spanish National Research...
Initiative of Excellence label confirmed for Université Paris Cité
Further to the international jury’s visit in September 2021, the Prime Minister has announced the permanent labeling of Université Paris Cité as an Initiative of Excellence.
The Contact Center Re-opens
The Contact Center will resume providing in-person service to students on appointment basis as of March 14, 2022. The Contact Center assists current and future students of the University with administrative formalities such as applications, administrative...
International Students, participate in the Campus France online survey !
Université Paris Cité, in cooperation with Campus France is launching an online survey on the living conditions of international students in France. The aim is to better understand their accommodations, resources and expenses related to their educational and leisure...
Call for Proposals for Circle U. collaborative projects
Funded by the French government (Programme d'investissements d'avenir - PIA), this call for proposals aims to strengthen collaboration between teacher-researchers, students and administrative staff by initiating projects in training, research, pedagogical innovation,...
Université Paris Cité, The new name of Université Paris Cité adopted by Decree
Further to an internal and external survey as well as a vote by its governing bodies, Université Paris Cité has become Université Paris Cité. The new name was approved by the Ministry of Higher Education, Research and Innovation, and was adopted by a decree of the...
An Interview with Paris-NUS PhD Mobility Grant Recipient Carmelo Alessandro Basile
In the framework of Université Paris Cité – National University of Singapore (NUS) partnership, Carmelo Alessandro Basile, PhD mobility grant recipient is currently pursuing his PhD at our university under the supervision of Prof. Agnès Celle and Prof. Debra Ziegeler...